Trade

Deccan Health Care share price

High risk
  • 47%Low risk
  • 47%Moderate risk
  • 47%Balanced risk
  • 47%High risk
  • 47%Extreme risk
  • ₹13.49(-1.68%)
    February 11, 2026 15:29:30 PM IST
    • NSE
    • BSE
  • Vol : 85.93 K (NSE + BSE)
    Last 20 day avg : 20.16 K

Deccan Health Care is trading -1.68% lower at Rs 13.49 as compared to its last closing price. Deccan Health Care has been trading in the price range of 14.10 & 13.40. Deccan Health Care has given -7.36% in this year & -1.51% in the last 5 days. The company posted a net profit of 0.91 Crores in its last quarter.Listed peers of Deccan Health Care include Sun Pharmaceutical Industries (0.14%), Divi's Laboratories (4.89%), Torrent Pharmaceuticals (-0.55%).The Mutual Fund holding in Deccan Health Care was at -% in . The MF holding has - from the last quarter. The FII holding in Deccan Health Care was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Feb 11, 2026, 01:26 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    1.04
    Medium volatility
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.00
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    0.30
    Lower than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    22.97
    Lower than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    0.73
    Indicates undervaluation
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    -
Price range
Day Range
Lowest
13.40
Highest
14.10
52 week range
Lowest
13.00
Highest
27.90
Deccan Health Care Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Bullish
1,709.950.144,10,264.6235.375.630.970.50
Divi's Laboratories
Bullish
6,474.504.891,72,371.9072.8910.680.500.01
Torrent Pharmaceuticals
Bullish
4,056.80-0.551,37,483.7669.1617.560.8117.62
Cipla
Moderately Bearish
1,349.400.541,09,000.7220.403.440.980.81
Dr Reddy's Laboratories
Bullish
1,266.100.831,05,545.7318.273.080.642.34
Deccan Health Care Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-12-11Others
2025-11-14Quarterly Results
2025-09-04Others
2025-08-14Quarterly Results
2025-06-16Others
About the company Deccan Health Care
  • IndustryBiotechnology & Drugs
  • ISININE452W01019
  • BSE Code542248
  • NSE Code
Deccan Health Care Limited is an India-based company, which is engaged in the business of manufacturing of nutraceuticals. The Company’s robust portfolio of 1500 market-ready products include 73 pioneering offerings and over 200 differentiated products. This includes several product classifications, such as immune, cardiovascular, digestive, personal care, weight management and other general health products. Its key categories of nutraceuticals, including vitamins and minerals, probiotics, proteins and peptides, omega fatty acids and others. Its nutraceuticals are available in several forms, including capsules, tablets, soft gels, powders, liquids, and gummies. They find applications in functional foods, functional beverages, dietary supplements and personal care products.
  • Management Info
  • Minto GuptaChairman of the Board, Managing Director
  • Parth PaleraChief Financial Officer
  • Mohita GuptaChief Operating Officer, Compliance Officer
  • Meenakshi GuptaAdditional Whole-Time Director
  • Mohak GuptaAdditional Whole time Director
  • Rani Umamaheswara RaoWhole Time Director
Deccan Health Care Share Price FAQs

Deccan Health Care is trading at 13.49 as on Wed Feb 11 2026 09:59:30. This is -1.68% lower as compared to its previous closing price of 13.72.

The market capitalization of Deccan Health Care is 31.60 Cr as on Wed Feb 11 2026 09:59:30.

The 52 wk high for Deccan Health Care is 27.90 whereas the 52 wk low is 13.00

Deccan Health Care can be analyzed on the following key metrics -

  • TTM P/E: 31.45
  • Sector P/E: -
  • Dividend Yield: 0.00%
  • D/E ratio: 0.02

Deccan Health Care reported a net profit of 1.20 Cr in 2025.

Quick Links
EQUITY QUICK LINKS
Deccan Health Care QUICK LINKS
FROM MARKETS
RELATED LINKS
Quarterly Results
Business News/Market/Market Stats/  Deccan Health Care share price